Tag: MACK

  • Early Gainers: Rediff.com India (NASDAQ:REDF), SunPower Corporation (NASDAQ:SPWR), Merrimack Pharmaceuticals Inc. (NASDAQ:MACK), ValueVision Media Inc. (NASDAQ:VVTV), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

    Rediff.com India Limited (ADR) (NASDAQ:REDF) one of the premier online providers of news, information, communication, entertainment and shopping services to Indians worldwide, announced results for its fourth quarter and fiscal year ended March 31, 2014. For the quarter ended March 31, 2014, the Company reported a 10% increase in overall revenues in rupee terms. In US Dollar terms, the overall revenues for the fourth fiscal quarter were $4.01 million, a 4% decline compared to $4.18 million reported in the comparable year-ago period.Rediff.com India Limited (ADR) (NASDAQ:REDF) stock opened today at $2.38 and is currently trading at $2.39. The stock showed a negative weekly performance of -15.38%.

    SunPower Corp. (NASDAQ:SPWR) has been selected by NV Energy to build a 19-megawatt (DC) solar photovoltaic power system at Nellis Air Force Base in Nevada. The system is expected to be constructed next year, contingent on contract approval by Nevada’s Public Utilities Commission. It will be the second major solar installation located at the military facility SunPower completed a 14-megawatt (DC) solar power system at the base in 2007. SunPower Corporation (NASDAQ:SPWR) stock opened at $33.61, in current trading session and currently is at $33.96, by gaining 6.09%. The 52 week range of $17.52 – $37.14. Company’s market capitalization is 5.87 billion.

    Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that Phase 1 clinical data from studies of MM-151, MM-141, MM-111 and MM-121 was presented at the 2014 American Society of Cancer Oncology (ASCO) Annual Meeting. Data from these studies support the clinical advancement of Merrimack’s novel antibody therapeutics. Merrimack Pharmaceuticals Inc. (NASDAQ:MACK) stock is currently trading at $7.41. The EPS of the stock is -1.30. Company’s market capitalization is 766.23 million.

    One such stock that you may want to consider dropping is ValueVision Media Inc. (NASDAQ:VVTV), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. Also, for the current quarter, ValueVision Media has seen 2 downward estimate revisions versus no revision in the opposite direction, dragging the consensus estimate down to 2 cents a share from 4 cents over the past 30 days. ValueVision Media Inc. (NASDAQ:VVTV) stock opened the session at $4.32, and now is at $4.35. The 52 week range of the ValueVision Media Inc. (NASDAQ:VVTV) stock remained $4.11 – $7.06 and the day range was $4.32 – $4.39.

    Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) announced that its Marketing Authorization Application (MAA) for oral HETLIOZ™ (tasimelteon) capsules has been accepted for evaluation by the European Medicines Agency (EMA) for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) stock opened today at $11.08 and is currently trading at $11.20. The stock showed a negative weekly performance of -6.70%.